India amongst the elite 12 biotechnology destinations in the world

Today, 26th February 2020, New Delhi is celebrating its 34th Foundation Day at the National Institute of Immunology (NII), New Delhi. Despite the economic slump of 2013-14, Indian industries related to biotechnologies have seen a constant rise, factoring to increasing…

Leap Therapeutics and BeiGene are announcing the exclusive option and license agreement for DKN-01 and Leap.

Leap Therapeutics and BeiGene are announcing the exclusive option and license agreement for DKN-01 and Leap.

Leap Therapeutics, Inc., a biotechnology company developing selective immuno-oncology medication, and BeiGene, Ltd., a commercial-stage biopharmaceutical company focusing on the development and marketing of novel molecular and immuno-oncology medicines for cancer treatment, today announced an exclusive right and licensing arrangement…

A clinical Trial conducted in United States proves that Light Therapy eradicates Cancer Cells 

The Chief Executive Officer and Chairman of Rakuten Medical Inc., Hiroshi Mikitani, has announced results of an early clinical study of the bio-venture company’s photoimmunotherapy therapy for patients with advanced stage head and neck cancers in Tokyo on July 1.…

ContraVir Pharmaceuticals sets the CRV431 Development’s stage

ContraVir Pharmaceuticals, Inc., a biopharmaceutical organization concentrated on the improvement of restorative medications for the treatment of liver illness emerging from non-alcoholic steatohepatitis (“NASH”) and unending viral contamination, today reported discoveries from a preclinical report where CRV431, a novel cyclophilin…